Is magnesium deficit in lymphocytes a part of the mitral valve prolapse syndrome?

Magnesium Research

Volumn 17, Issue 1, 2004, Pages 39-45

  Kitliński, Mariusz ^a,c   Stȩpniewski, Marek ^b   Nessler, Jadwiga ^b   Konduracka, Ewa ^b   Solarska, Katarzyna ^b   Piwowarska, Wiesława ^b   Erhardt, Leif ^a  

^a LUND UNIVERSITY   (Sweden)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c NONE   (Sweden)

Author keywords

Magnesium; Magnesium deficiency; Mitral valve prolapse

Indexed keywords

MAGNESIUM;

ADOLESCENT; ADULT; AGE; ARTICLE; CELL ISOLATION; CELL LYSATE; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; LYMPHOCYTE; MAGNESIUM DEFICIENCY; MALE; MEASUREMENT; MITRAL VALVE PROLAPSE; PLASMA; STATISTICAL SIGNIFICANCE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DIETARY SUPPLEMENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; LYMPHOCYTES; MAGNESIUM; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; MITRAL VALVE PROLAPSE; SYNDROME;

EID: 1642390769     PISSN: 09531424     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Barlow JB, Pocock WA, Marchand P, Denny M. The significance of late systolic murmurs. Am Heart J 1963; 66: 443-52.
2. Barlow JB. Mitral valve billowing and prolapse - an overview. Aust NZJ Med 1992; 22: 541-9.
3. Boudoulas H, Wooley CF. Mitral valve prolapse and the mitral valve prolapse syndrome. Mount Kisco, N.Y., Futura Publ. Comp., 1988.
4. Savage D.D., Garrison R.J., Devereux R.B. et al. Mitral valve prolapse in the general population. 1. Epidemiologic features: The Framingham Study. Am Heart J 1983; 106: 571-6.
5. Levine RA, Triulzi MO, Harrigan P, Weyman AE. The relationship of mitral annular shape to the diagnosis of mitral valve prolapse. Circulation 1987; 75: 756-67.
6. Shah PM. Echocardiographic Diagnosis of Mitral Valve Prolapse. J Am Soc Echocardiogr 1994; 7 (3 Pt 1): 286-93.
7. Savage DD, Devereux RB, Garrison RJ, et al. Mitral valve prolapse in the general population. 2. Clinical features: The Framingham Study. Am Heart J 1983; 106: 577-81.
8. Devereux RB. Recent developments in the diagnosis and management of mitral valve prolapse. Curr Opin Cardiol 1995; 10: 107-16.
9. Piwowarska W, Kitliński M. Symptomatic and asymptomatic mitral valve prolapse. Diagnosis and treatment. Cracow, The Polish Fundation of Laboratory Diagnosis, 1993.
10. Durlach J. Tétanie latente et prolapsus mitral par déficit magnésique chronique primaire. Presse Thermale et Climatique, 1983; 120: 21-7.
11. Durlach J, Durlach V. Idiopathic mitral valve prolapse and magnesium: State of the art. Magn. Bull. 1986; 8: 156-69.
12. Galland LD, Baker SM, McLellan RK. Magnesium deficiency in the pathogenesis of mitral valve prolapse. Magnesium 1986; 5: 165-74.
13. Durlach J. Primary mitral valve prolapse: a clinical form of primary magnesium deficit. Magnes Res 1994 Dec; 7(3-4): 339-40.
14. Carney RM, Freedland KE, Ludbrook PA, Saunders RD, Jaffe AS. Major depression, panic disorder, and mitral valve prolapse in patients who complain of chest pain. Am J Med 1990; 89: 757-60.
15. Anwar A, Kohn SR, Dunn JF, et al. Altered β-adrenergic receptor function in subjects with symptomatic mitral valve prolapse. Am J Med Sci 1991; 302: 89-97.
16. Boudoulas H, Reynolds JC, Mazzaferri E, Wooley CF. Metabolic studies in mitral valve prolapse syndrome. A neuroendocrine-cardiovascular process. Circulation 1980; 61: 1200-5.
17. Sniezek-Maciejewska M, Dubiel JP, Piwowarska W, et al. Ventricular arrhythmias and the autonomic tone in patients with mitral valve prolapse. Clin Cardiol 1992; 15: 720-4.
18. Durlach J, Lutfalla G, Poenaru S, Reba A, Henrotte JG, Fabiani F, de Vernejoul F. "Latent tetany and mitral valve prolapse due to chronic primary magnesium deficit". In: Halpern MJ, Durlach J. Magnesium deficiency. Physiopathology and treatment implications. Karger publ. Bâle-N.Y., 1985: 102-12.
19. Cohen L, Bitterman H, Grenadier E, et al. Idiopathic magnesium deficiency in mitral valve prolapse. Am J Cardiol 1986; 57: 486-7.
20. Lucionni R, Gerard R. Prolapsus valvulaire mitral, spasmophilie et magnesium. Gaz Med France 1980; 87: 643-7.
21. Durlach J, de Vernejoul F, Poenaru S, et al. Tetanie latente par deficit magnesique chronic et prolapsus idiopathique de la valve mitrale (Maladie de Barlow): etude de correlations echo-electrocliniques. Magn Bull 1982; 1: 55-61.
22. Frances Y, Collet F, Luccioni R. Long-term follow-up of mitral valve prolapse and latent tetany. Magnesium 1986; 5: 175-81.
23. Coghlan HC, Natello G. Erythrocyte magnesium in symptomatic patients with primary mitral valve prolapse: relationship to symptoms, mitral leaflet thickness, joint hypermobility and autonomie regulation. Magnes Trace Elem 1991-92; 10: 205-14.
24. Piwowarska W, Kitliński M. Magnesium and cardiac arrhythmias in 84 people with mitral valve prolapse. Philippine J Cardiol 1990; Suppl.: I-295.
25. Ross R, Seelig M, Berger A. Isolation of leukocytes for magnesium determination; in Cantin M., Seelig M. (eds): Magnesium in Health and Disease. New York, Spectrum, 1980, pp: 7-15.
26. Perloff JK, Child JS, Edwards JE. New guidelines for the clinical diagnosis of mitral valve prolapse. Am J Cardiol 1986; 57: 1124-9.
27. Boyum A. Separation of leucocytes from blood and bone marrow. Scand J Clin Lab Invest. suppl. 1968; 21: 97.
28. Treves AJ, Yagodo D, Haimovitz A, et al. The isolation and purification of human peripheral blood monocytes in cell suspension. J Immunol Methods 1980; 39: 71-6.
29. Piwowarska W, Mroczek-Czernecka D. Follow-up of patients with mitral valve prolapse presenting with rhythm disturbances. Ann Clin Res 1988; 20: 389-92.
30. Buda AJ, Levene DL, Myers MG, Chisholm AW, Shane SJ. Coronary artery spasm and mitral valve prolapse. Am Heart J 1978; 95: 457-62.
31. Gullace G, Nicolli GP, Beghelli G, et al. Studio clinico et strumantale del prollasso della valvula mitrale. G Ital Cardiol 1977; 7: 348-59.
32. Durlach J, Bac P, Durlach V, Bara M, Guiet-bara A. Neurotic, neuromuscular and autonomie nervous form of magnesium imbalance. Magnes Res 1997 Jun; 10(2): 169-95, Review.
33. Kitliński M, Konduracka E, Piwowarska W, Stepniewski M, Nessler J, Mroczek-Czernecka D, Solarska K. Evaluation of magnesium cation levels in serum of patients with mitral valve prolapse syndrome. Folia Med Carcov 2000; 41 (3-4): 17-24.
34. Flink EB. Magnesium deficiency. Etiology and clinical spectrum. Acta Med Scand 1981; Suppl. 647: 125-37.
35. Lichodziejewska B, Klos J, Rezler J, et al. Clinical symptoms of mitral valve prolapse are related to hypomagnesemia and attenuated by magnesium supplementation. Am J Cardiol 1997; 79: 768-72.
36. Halpern MJ, Durlach J. Magnesium deficiency. Physiopathology and treatment implications. Karger publ. Bâle-N.Y., 1985: 102-12
37. Dyckner T, Wester P.O. Relation between potassium, magnesium and cardiac arrhythmias. Acta Med Scand 1981; suppl. 647: 163-9.
38. Kligfield P, Levy D, Devereux RB, Savage DD. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J 1987; 113: 1298-307.
39. Babuty D, Fauchier L, Neel Ch, Cosnay P, Fauchier JP. Arrhythmias and sudden death in patients with mitral valve prolapse. Cardiac Electrophysiol Rev 1997; 1/2: 264-7.
40. Zwanzger P, Baghai T, Schule C, Rupprecht R. Treatment of mitral valve prolapse and panic disorder with metoprolol. World J Biol Psychiatry 2000; 1(2): 124-5.
41. Alpert MA, Sabeti M, Kushner MG, et al. Frequency of isolated panic attacks and panic disorder in patients with mitral valve prolapse syndrome. Am J Cardiol 1992; 69: 1489-90.
42. Durlach J, Bac P, Bara M, Guiet-Bara A. Physiopathology of symptomatic and latent forms of central nervous hyperexcitability due to magnesium deficiency a current general scheme. Magnes Res 2000 Dec; 13(4): 293-302, Review.
43. Pasternac A, Tubau JF, Puddu PE, et al. Increased plasma catecholamine levels in patients with symptomatic mitral valve prolapse. Am J Med 1982; 73: 783-90.
44. Terechtchenko L, Doronina SA, Pochinok EM, Riftine A. Autonomic tone in patients with supraventricular arrhythmia associated with mitral valve prolapse in young men. Pacing Clin Electrophysiol 2003; 26 (1 Pt 2): 444-6.
45. Boudoulas H, Wooley CF. Floppy mitral valve/mitral valve prolapse/mitral valvular regurgitation: effects on the circulation. J Cardiol 2001; 37 Suppl. 1: 15-20.
46. Mulumudi MS, Vivekananthan K. Mysteries of mitral valve prolapse. Proper treatment require consideration of all clues. Postgrad Med 2001; 110 (2): 43-4, 47-8, 53-4.
47. Babuty D, Casset-Senon D, Fauchier L, Giraudeau C, Fauchier JP, Cosnay P. Mitral valve prolapse and cardiac arrhythmias. Card Electrophysiol Rev 2002; 6 (1-2): 129-31.
48. Jacobs W, Chamoun A, Stouffer GA: Mitral valve prolapse: a review of the literature. Am J Med Sci 2001; 321 (6): 401-10.
49. James PA, Aftimos S, Skinner JR. Familial mitral valve prolapse associated with short stature, characteristic face, and sudden death. Am J Med Genet 2003; 119 a (1): 32-6.
50. Freed LA, Acierno JS Jr, Dai D, Leyne M, Marshall JE, Nesta F, Levy RA, Slaugenhaupt SA. A locus for autosomal dominant mitral valve prolapse on chromosome 11p15.4. Am J Hum Genet 2003; 72 (6): 1551-9.